NAME Dr Douglas Fairlie
CANCER TYPE Lung cancer
INSTITUTION Olivia Newton-John Cancer Research Institute
GRANT TYPE $50,000
PROJECT TYPE Research
New treatment strategies for mesothelioma
"The overarching aim of the project is to extend our promising in vitro studies into whole animals. This will be achieved by examining the effects of BH3-mimetic drugs in a number of mouse models. We will also determine whether combinations of BH3-mimetics with other anti-cancer therapies can also improve treatment outcomes."
- Dr Douglas Fairlie, Olivia Newton-John Cancer Research Institute